Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2025 Earnings Call Transcript February 12, 2026
Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.82 EPS, expectations were $1.16.
Operator: Good morning, ladies and gentlemen, and welcome to the Alnylam Pharmaceuticals, Inc. Q4 and Full Year 2025 Earnings Conference Call. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance,...
